Association of body mass index and visceral fat with aortic valve calcification and mortality after transcatheter aortic valve replacement: the obesity paradox in severe aortic stenosis

[1] Hubert HB(1983)Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study Circulation 67 968-977

[2] Mathieu P(2007)The ‘valvulo-metabolic’ risk in calcific aortic valve disease Can J Cardiol 23 32b-39b

[3] Despres JP(1999)Body-mass index and mortality in a prospective cohort of U.S. adults N Engl J Med 341 1097-1105

[4] Pibarot P(2009)Relationship of metabolic syndrome with incident aortic valve calcium and aortic valve calcium progression: the Multi-Ethnic Study of Atherosclerosis (MESA) Diabetes 58 813-819

[5] Calle EE(2012)Impact of metabolic syndrome on progression of aortic stenosis: influence of age and statin therapy J Am Coll Cardiol 60 216-223

[6] Katz R(2010)Metabolic syndrome is associated with more pronounced impairment of left ventricle geometry and function in patients with calcific aortic stenosis: a substudy of the ASTRONOMER (Aortic Stenosis Progression Observation Measuring Effects of Rosuvastatin) J Am Coll Cardiol 55 1867-1874

[7] Capoulade R(2013)Effect of overweight and obesity on cardiovascular events in asymptomatic aortic stenosis: a SEAS substudy (Simvastatin Ezetimibe in Aortic Stenosis) J Am Coll Cardiol 62 1683-1690

[8] Page A(2011)Effect of body mass index on survival in patients having aortic valve replacement for aortic stenosis with or without concomitant coronary artery bypass grafting Am J Cardiol 108 1767-1771

[9] Rogge BP(2015)Body mass index, outcomes, and mortality following cardiac surgery in Ontario, Canada J Am Heart Assoc 4 e002140-1937

[10] Roberts WC(2013)Effect of body mass index on 30- and 365-day complication and survival rates of transcatheter aortic valve implantation (from the FRench Aortic National CoreValve and Edwards 2 [FRANCE 2] registry) Am J Cardiol 112 1932-450

[1] Hubert HB(1983)Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study Circulation 67 968-977

[2] Mathieu P(2007)The ‘valvulo-metabolic’ risk in calcific aortic valve disease Can J Cardiol 23 32b-39b

[3] Despres JP(1999)Body-mass index and mortality in a prospective cohort of U.S. adults N Engl J Med 341 1097-1105

[4] Pibarot P(2009)Relationship of metabolic syndrome with incident aortic valve calcium and aortic valve calcium progression: the Multi-Ethnic Study of Atherosclerosis (MESA) Diabetes 58 813-819

[5] Calle EE(2012)Impact of metabolic syndrome on progression of aortic stenosis: influence of age and statin therapy J Am Coll Cardiol 60 216-223

[6] Katz R(2010)Metabolic syndrome is associated with more pronounced impairment of left ventricle geometry and function in patients with calcific aortic stenosis: a substudy of the ASTRONOMER (Aortic Stenosis Progression Observation Measuring Effects of Rosuvastatin) J Am Coll Cardiol 55 1867-1874

[7] Capoulade R(2013)Effect of overweight and obesity on cardiovascular events in asymptomatic aortic stenosis: a SEAS substudy (Simvastatin Ezetimibe in Aortic Stenosis) J Am Coll Cardiol 62 1683-1690

[8] Page A(2011)Effect of body mass index on survival in patients having aortic valve replacement for aortic stenosis with or without concomitant coronary artery bypass grafting Am J Cardiol 108 1767-1771

[9] Rogge BP(2015)Body mass index, outcomes, and mortality following cardiac surgery in Ontario, Canada J Am Heart Assoc 4 e002140-1937

[10] Roberts WC(2013)Effect of body mass index on 30- and 365-day complication and survival rates of transcatheter aortic valve implantation (from the FRench Aortic National CoreValve and Edwards 2 [FRANCE 2] registry) Am J Cardiol 112 1932-450